PubRank

Vincenzo Pezzi

Author PubWeight™ 36.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 2004 2.36
2 Expression of aromatase and estrogen receptors in human adrenocortical tumors. Virchows Arch 2007 1.44
3 The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line. Endocrinology 2008 1.34
4 Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology 2002 1.16
5 Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. Mol Cell Endocrinol 2010 1.14
6 Retracted G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells. Environ Health Perspect 2008 1.13
7 Synthesis and biological activity of 7-phenyl-6,9-dihydro-3H-pyrrolo[3,2-f]quinolin-9-ones: a new class of antimitotic agents devoid of aromatase activity. J Med Chem 2006 1.07
8 Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue. Mol Cell Endocrinol 2004 1.04
9 17 beta-estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ER alpha. Mol Cell Endocrinol 2010 1.02
10 Effects of atrazine on estrogen receptor α- and G protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblasts. Environ Health Perspect 2015 1.00
11 Leptin secretion by human ejaculated spermatozoa. J Clin Endocrinol Metab 2005 0.99
12 Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones. J Med Chem 2005 0.98
13 Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation. Cancer Res 2007 0.94
14 Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system. J Cell Physiol 2012 0.93
15 The nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs). Mol Cell Endocrinol 2013 0.92
16 Detection of aromatase and estrogen receptors (ERalpha, ERbeta1, ERbeta2) in human Leydig cell tumor. Eur J Endocrinol 2007 0.91
17 Cross-talk between GPER and growth factor signaling. J Steroid Biochem Mol Biol 2013 0.91
18 Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation. Mol Nutr Food Res 2010 0.87
19 Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of Leydig tumor cells. J Biol Chem 2009 0.86
20 Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment. J Clin Endocrinol Metab 2012 0.86
21 A new role of anandamide in human sperm: focus on metabolism. J Cell Physiol 2009 0.85
22 Potential of olive oil phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies. Mol Nutr Food Res 2012 0.84
23 Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells. J Mol Endocrinol 2004 0.84
24 Structure-activity relationships of resveratrol and derivatives in breast cancer cells. Mol Nutr Food Res 2009 0.84
25 SLC37A1 gene expression is up-regulated by epidermal growth factor in breast cancer cells. Breast Cancer Res Treat 2009 0.84
26 Localization and regulation of aromatase liver receptor homologue-1 in the developing rat testis. Mol Cell Endocrinol 2010 0.83
27 Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells. Mol Nutr Food Res 2013 0.82
28 Aromatase overexpression enhances the stimulatory effects of adrenal androgens on MCF7 breast cancer cells. Mol Cell Endocrinol 2002 0.80
29 17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line. Mol Cell Endocrinol 2012 0.79
30 The AP-1 family member FOS blocks transcriptional activity of the nuclear receptor steroidogenic factor 1. J Cell Sci 2010 0.79
31 Antioxidant activity of a Mediterranean food product: "fig syrup". Nutrients 2011 0.78
32 Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: part I. J Enzyme Inhib Med Chem 2011 0.78
33 Triiodothyronine decreases the activity of the proximal promoter (PII) of the aromatase gene in the mouse Sertoli cell line, TM4. Mol Endocrinol 2003 0.78
34 Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines. Bioorg Med Chem Lett 2013 0.77
35 Synthesis and cytotoxic activity evaluation of 2,3-thiazolidin-4-one derivatives on human breast cancer cell lines. Bioorg Med Chem Lett 2013 0.77
36 Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors. J Med Chem 2013 0.76
37 cAMP-dependent regulation of CYP19 gene in rabbit preovulatory granulosa cells and corpus luteum. J Steroid Biochem Mol Biol 2009 0.76
38 Retinoylation reaction of proteins in Leydig (TM-3) cells. J Bioenerg Biomembr 2005 0.76
39 Synthesis of a new bis(indolyl)methane that inhibits growth and induces apoptosis in human prostate cancer cells. Nat Prod Res 2013 0.75
40 Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation. Mol Cell Endocrinol 2012 0.75